Pasireotide
Pasireotide
6 Amino Acids · MW: N/A
Amino Acids
6
Molecular Weight
N/A
Half-life
12-24 hours
Research Score
4.6
Studies
1200
Storage
Store lyophilized at -20°C, reconstituted at 2-8°C
What is Pasireotide?
Broad-spectrum somatostatin analog with higher affinity for several somatostatin receptor subtypes than octreotide. It has been studied for acromegaly and Cushing's disease where stronger suppression of pituitary signaling may be useful.
Key Benefits & Mechanisms
multi-receptor somatostatin signaling
GH suppression
IGF-1 reduction
endocrine tumor research
Research Summary
Pasireotide was developed to expand somatostatin receptor coverage beyond older analogs and has been explored in difficult-to-control endocrine disorders. Research consistently shows potent hormone suppression but a greater tendency toward glucose disturbances than first-generation analogs.
Related Peptides
Ibutamoren
Ibutamoren mesylate (MK-677)
Ibutamoren is an orally active ghrelin receptor agonist that increases pulsatile growth hormone and IGF-1 secretion. It has been studied for effects on lean mass, recovery, and age-related anabolic support.
Growth HormoneAnamorelin
Anamorelin hydrochloride (ONO-7643)
Anamorelin is a selective ghrelin receptor agonist developed to stimulate appetite and growth hormone signaling. It has been investigated primarily in cancer cachexia and other wasting states.
Growth HormoneMacimorelin
Macimorelin acetate (AEZS-130)
Macimorelin is an orally active ghrelin mimetic used as a growth hormone stimulation agent. It produces a rapid GH rise after a single dose and is used clinically to help diagnose adult GH deficiency.
Growth HormoneCapromorelin
Capromorelin hydrochloride
Capromorelin is a ghrelin receptor agonist that stimulates growth hormone release and increases appetite. It is best known in veterinary medicine, but it has also been explored in human research settings.
Growth Hormone